Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

XPAD European Feasibility Study

NCT: NCT07716020 · NOT_YET_RECRUITING

NCT IDNCT07716020
StatusNOT_YET_RECRUITING
Start Date2026-12
Completion2032-12
SponsorXeltis (INDUSTRY)
First posted
Last updated

Brief Summary

A prospective, single arm, non-randomized European feasibility study to evaluate the safety and performance of the XPAD conduit in patients with peripheral arterial occlusive disease (PAOD), scheduled to undergo elective lower-limb, above or below the knee, bypass surgery.

Frequently Asked Questions

What is XPAD European Feasibility Study?

XPAD European Feasibility Study is a clinical trial registered under NCT07716020. Current status: NOT_YET_RECRUITING.

What is the status of NCT07716020?

The current status of NCT07716020 (XPAD European Feasibility Study) is: NOT_YET_RECRUITING.

When did XPAD European Feasibility Study start?

XPAD European Feasibility Study started on 2026-12.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.